Jasper Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.
Jasper Therapeutics stock last closed at $0.50, down 1.59% from the previous day, and has decreased 79.33% in one year. It has underperformed other stocks in the Biotechnology industry by 0.13 percentage points. Jasper Therapeutics stock is currently +57.46% from its 52-week low of $0.32, and -80.25% from its 52-week high of $2.51.
As of Oct 22, 2026, there are 33.27M JSPR shares outstanding. The market capitalization of JSPR is $16.50M. In the last 24 hours, 72,000 JSPR shares were traded.
You need a brokerage account to access the NASDAQ market and buy JSPR shares.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, it's time to fill out some personal info so you are able to invest in JSPR today.
Now that you have filled out your info on our top ranked stock trading app, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of transferring funds into your new brokerage account.
Once you have chosen the best place to buy Jasper Therapeutics stock, it's absolutely critical to analyze their stock before you invest, so you truly understand the risk as well as the upside.
WallStreetZen was created to help part-time investors do better fundamental analysis quickly.
You can view all of the due diligence checks on JSPR's stock page.
You can use many financial metrics, analyses, models, and charts to gauge JSPR's true value.
Using relative valuations metrics:
You can access more valuation research on JSPR's stock here.
Out of 4 Equities analysts who monitor JSPR, the consensus analyst rating on Jasper Therapeutics is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Jasper Therapeutics stock forecast page.
In the last year, insiders at JSPR have not bought or sold any shares.
Research more about who owns JSPR stock here.
No, Jasper Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary types of orders:
Click the Open button and your broker will place your order.
If you require additional info about investing in stocks on eToro, click the helpful video below:
Now that you own some shares in JSPR, you'll want to stay up-to-date on your new company.
Create a watchlist to monitor your JSPR stock.
To summarize, here are the 6 steps to buy Jasper Therapeutics stock:
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Jasper Therapeutics, add JSPR to your watchlist below.